Smith Shellnut Wilson LLC Corcept Therapeutics Inc Transaction History
Smith Shellnut Wilson LLC
- $257 Million
- Q3 2025
A detailed history of Smith Shellnut Wilson LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Smith Shellnut Wilson LLC holds 4,819 shares of CORT stock, worth $357,425. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,819
Previous 4,819
-0.0%
Holding current value
$357,425
Previous $353,000
13.31%
% of portfolio
0.16%
Previous 0.15%
Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
481Shares Held
83.4MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.23 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$718 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$573 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$465 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$287 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.94B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...